These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32114421)

  • 1. EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells.
    Kumar A; Golani A; Kumar LD
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):979-1010. PubMed ID: 32114421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
    Peng F; Xiong L; Tang H; Peng C; Chen J
    Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
    Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
    Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
    Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
    Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
    Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
    Zhao M; Ang L; Huang J; Wang J
    Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    Anderson O; Guttilla Reed IK
    PLoS One; 2020; 15(5):e0233187. PubMed ID: 32396572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of mesenchymal phenotype by MicroRNAs in cancer.
    Yan J; Gumireddy K; Li A; Huang Q
    Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
    Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
    Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
    Yu M; Bardia A; Wittner BS; Stott SL; Smas ME; Ting DT; Isakoff SJ; Ciciliano JC; Wells MN; Shah AM; Concannon KF; Donaldson MC; Sequist LV; Brachtel E; Sgroi D; Baselga J; Ramaswamy S; Toner M; Haber DA; Maheswaran S
    Science; 2013 Feb; 339(6119):580-4. PubMed ID: 23372014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.
    Fan M; Sethuraman A; Brown M; Sun W; Pfeffer LM
    Breast Cancer Res Treat; 2014 Aug; 146(3):487-502. PubMed ID: 25001613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.
    Ding X; Park SI; McCauley LK; Wang CY
    J Biol Chem; 2013 Apr; 288(15):10241-53. PubMed ID: 23447531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.
    Hong S; Noh H; Teng Y; Shao J; Rehmani H; Ding HF; Dong Z; Su SB; Shi H; Kim J; Huang S
    Neoplasia; 2014 Apr; 16(4):279-90.e1-5. PubMed ID: 24746361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
    Zhai L; Ma C; Li W; Yang S; Liu Z
    Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
    Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
    Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.